John Bessey: His doctor said he was fine. The blood work said otherwise.
2 Commas: The $multi-million exit show with Josh Comrie by Josh Comrie
Episode notes
Most of us have no idea what's actually going on inside our body.
John Bessey has been in the room for three major tech exits as CEO of Merkle (Davanti), head of revenue at Introgen, and on the executive team when Gen-I sold to Spark. He's also a certified metabolic and health coach who reckons most high-performers are flying blind on the things that actually matter and he's got the blood work to prove it.
In this episode, John and I get into the overlap between building a high-performing business and building a body that doesn't quit before the game's over. He shares what actually worked when he stepped in as an external CEO and why most of those appointments fail, how Divanti's earn-out structure gave the founders real control through the sale, and the simple rituals he uses with executives to cut distraction and fi ...